• Artelo Biosciences set a 1-for-9 reverse stock split, effective for Nasdaq trading at the Aug. 31 open.
• Reverse split combines every nine common shares into one, aiming to lift the share price to support liquidity.
• Outstanding warrants and other derivatives will adjust under their terms to reflect the split.
• Post-split common shares outstanding expected at about 547,774.
• New post-split CUSIP: 04301G805.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608270800PRIMZONEFULLFEED9816592) on August 27, 2026, and is solely responsible for the information contained therein.